South Korea · Delayed Price · Currency is KRW WOOJUNG BIO Statistics
Total Valuation
WOOJUNG BIO has a market cap or net worth of KRW 39.97 billion. The enterprise value is 55.68 billion.
| Market Cap | 39.97B |
| Enterprise Value | 55.68B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
WOOJUNG BIO has 16.83 million shares outstanding. The number of shares has increased by 4.43% in one year.
| Current Share Class | 16.83M |
| Shares Outstanding | 16.83M |
| Shares Change (YoY) | +4.43% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 33.61% |
| Owned by Institutions (%) | n/a |
| Float | 4.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.99 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 1.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.38 |
| EV / EBITDA | 29.71 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 2.28.
| Current Ratio | 0.80 |
| Quick Ratio | 0.65 |
| Debt / Equity | 2.28 |
| Debt / EBITDA | 28.14 |
| Debt / FCF | -13.83 |
| Interest Coverage | -0.64 |
Financial Efficiency
Return on equity (ROE) is -14.57% and return on invested capital (ROIC) is -3.35%.
| Return on Equity (ROE) | -14.57% |
| Return on Assets (ROA) | -1.06% |
| Return on Invested Capital (ROIC) | -3.35% |
| Return on Capital Employed (ROCE) | -3.23% |
| Weighted Average Cost of Capital (WACC) | 5.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.38 |
| Inventory Turnover | 3.97 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.24% in the last 52 weeks. The beta is 0.49, so WOOJUNG BIO's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +26.24% |
| 50-Day Moving Average | 2,734.30 |
| 200-Day Moving Average | 2,320.75 |
| Relative Strength Index (RSI) | 42.01 |
| Average Volume (20 Days) | 94,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WOOJUNG BIO had revenue of KRW 40.30 billion and -3.68 billion in losses. Loss per share was -220.47.
| Revenue | 40.30B |
| Gross Profit | 11.44B |
| Operating Income | -1.82B |
| Pretax Income | -3.68B |
| Net Income | -3.68B |
| EBITDA | 1.88B |
| EBIT | -1.82B |
| Loss Per Share | -220.47 |
Balance Sheet
The company has 37.09 billion in cash and 52.80 billion in debt, with a net cash position of -15.71 billion or -933.48 per share.
| Cash & Cash Equivalents | 37.09B |
| Total Debt | 52.80B |
| Net Cash | -15.71B |
| Net Cash Per Share | -933.48 |
| Equity (Book Value) | 23.17B |
| Book Value Per Share | 1,389.72 |
| Working Capital | -12.73B |
Cash Flow
In the last 12 months, operating cash flow was -3.74 billion and capital expenditures -79.45 million, giving a free cash flow of -3.82 billion.
| Operating Cash Flow | -3.74B |
| Capital Expenditures | -79.45M |
| Depreciation & Amortization | 3.70B |
| Net Borrowing | 33.13B |
| Free Cash Flow | -3.82B |
| FCF Per Share | -226.78 |
Margins
Gross margin is 28.39%, with operating and profit margins of -4.52% and -9.12%.
| Gross Margin | 28.39% |
| Operating Margin | -4.52% |
| Pretax Margin | -9.12% |
| Profit Margin | -9.12% |
| EBITDA Margin | 4.66% |
| EBIT Margin | -4.52% |
| FCF Margin | n/a |
Dividends & Yields
WOOJUNG BIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.43% |
| Shareholder Yield | -4.43% |
| Earnings Yield | -9.20% |
| FCF Yield | -9.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.
| Last Split Date | Jul 30, 2019 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | 0 |
| Piotroski F-Score | 1 |